AI assistant
ClearPoint Neuro, Inc. — Director's Dealing 2025
Jun 12, 2025
32641_dirs_2025-06-11_c6d0ace8-bbed-4d05-a076-eb82399dd24e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2025-06-09
Reporting Person: BURNETT JOSEPH (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-09 | Common Stock | S | 21247 | $13.29 | Disposed | 243522 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 25363 | Direct |
Footnotes
F1: This sale of shares is incident to the net share settlement of 21,247 shares which vested on March 6, 2025 under a restricted stock unit granted to the reporting person on March 6, 2023.
F2: Represents a weighted average sales price per share. The shares were sold at prices ranging from $13.20 to $13.51. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3: These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.